A detailed history of Nalls Sherbakoff Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 1,673 shares of MRK stock, worth $175,380. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,673
Previous 1,689 0.95%
Holding current value
$175,380
Previous $174 Million 4.89%
% of portfolio
0.16%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

SELL
$100.18 - $109.02 $1,602 - $1,744
-16 Reduced 0.95%
1,673 $182 Million
Q2 2023

Oct 17, 2023

SELL
$108.61 - $118.38 $54,305 - $59,190
-500 Reduced 22.84%
1,689 $186 Million
Q1 2023

Oct 17, 2023

BUY
$102.94 - $114.86 $86,057 - $96,022
836 Added 61.79%
2,189 $232 Million
Q4 2018

Feb 15, 2019

BUY
$65.24 - $75.71 $79,462 - $92,214
1,218 Added 902.22%
1,353 $103,000
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $8,807 - $10,220
135 New
135 $106,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $266B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.